Clinical Trials at Heart Group of the Eastern Shore
During the past decade, Heart Group of the Eastern Shore conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on
average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone on Morbidity (Events Indicating Disease Worsening) & Mortality (Death Rate) in Participants With Heart Failure and Left Ventricular Ejection Fraction (Proportion of Blood Expelled Per Heart Stroke) Greater or Equal to 40%
A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke
2022-12-05
2025-08-25
Recruiting
18,000
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Heart Group of the Eastern Shore"
#1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "George Clinical Pty Ltd" with 1 trials as a collaborator and "Saint Luke's Hospital of Kansas City" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Heart Group of the Eastern Shore
According to Clinical.Site data, the most researched conditions in "Heart Group of the Eastern Shore" are
"Atrial Fibrillation" (1 trials), "COVID-19" (1 trials), "Chronic Heart Failure With Preserved Systolic Function" (1 trials), "Chronic Heart Failure With Reduced Systolic Function" (1 trials) and "Heart Failure" (1 trials). Many other conditions were trialed in "Heart Group of the Eastern Shore" in a lesser frequency.
Clinical Trials Intervention Types at Heart Group of the Eastern Shore
Most popular intervention types in "Heart Group of the Eastern Shore" are "Drug" (5 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Dapagliflozin matching placebo" (2 trials), "Placebo" (2 trials), "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials) and "Asundexian (BAY2433334)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Heart Group of the Eastern Shore
The vast majority of trials in "Heart Group of the Eastern Shore" are
5 trials for "All" genders.
Clinical Trials Status at Heart Group of the Eastern Shore
Currently, there are NaN active trials in "Heart Group of the Eastern Shore".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Heart Group of the Eastern Shore,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Heart Group of the Eastern Shore, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 0 trials that are defined as “Not Applicable".